Sabrina Bonomini

2.9k citations
49 papers · 2.0k indexed · h-index 23
Topics
Multiple Myeloma Research and Treatments (26 papers)Peptidase Inhibition and Analysis (9 papers)Bone health and treatments (7 papers)
Partner nations
ItalyBrazilUnited States

In The Last Decade

Sabrina Bonomini

44 papers receiving 2.0k citations

Peers

Sabrina Bonomini
Comparison fields: 5 of 96
  • Oncology 1.0k
  • Hematology 949
  • Molecular Biology 893
  • Genetics 267
  • Surgery 221
Replace Berno Dankbar with:
Berno Dankbar Germany
Scott T. Avecilla United States
Kathryn Weibrecht United States
Koichi Hattori Japan
Belén Blanco Spain
Myrtle Y. Gordon United Kingdom
Isabelle Vande Broek Belgium
Frederick A. Fletcher United States
Enrique J. Andreu Spain
Riitta Alitalo Finland
Sabrina Bonomini relative to Berno Dankbar Germany Berno Dankbar's profile →
Citations per field
00.5×3.9×
Berno Dankbar · 1×
Citations per year

Countries citing papers authored by Sabrina Bonomini

Since Specialization
Citations

This map shows the geographic impact of Sabrina Bonomini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabrina Bonomini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabrina Bonomini more than expected).

Fields of papers citing papers by Sabrina Bonomini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabrina Bonomini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabrina Bonomini. The network helps show where Sabrina Bonomini may publish in the future.

Co-authorship network of co-authors of Sabrina Bonomini

This figure shows the co-authorship network connecting the top 25 collaborators of Sabrina Bonomini. A scholar is included among the top collaborators of Sabrina Bonomini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabrina Bonomini. Sabrina Bonomini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 13
4 32
5 11
6 45
7 19
8 10
9 81
10 65
11 38
12 42
13 88
14 38
15 5
16 10
17 98
18 3
19 68
20 1

About Sabrina Bonomini

Sabrina Bonomini is a scholar working on Hematology, Genetics and Oncology, having authored 49 papers that have together received 2.0k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (26 papers), Peptidase Inhibition and Analysis (9 papers) and Bone health and treatments (7 papers). The work is most often cited by research in Hematology (949 citations), Oncology (1.0k citations) and Genetics (267 citations). Sabrina Bonomini has collaborated with scholars based in Italy, Brazil and United States. Frequent co-authors include Nicola Giuliani, Vittorio Rizzoli, Mirca Lazzaretti, Simona Colla, Francesca Morandi, Roberto Sala, Edoardo Raposio, Paola Storti, Marina Bolzoni and Sara Tagliaferri. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026